Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults, Medical Mycology, vol.140, issue.4, pp.361-370, 2013. ,
DOI : 10.1093/cid/cir179
URL : https://academic.oup.com/mmy/article-pdf/51/4/361/3407031/51-4-361.pdf
Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis, Bulletin of the World Health Organization, vol.89, issue.12, pp.864-872, 2011. ,
DOI : 10.2471/BLT.11.089441
URL : http://doi.org/10.2471/blt.11.089441
Global burden of chronic pulmonary aspergillosis complicating sarcoidosis, European Respiratory Journal, vol.41, issue.3, pp.621-626, 2013. ,
DOI : 10.1183/09031936.00226911
URL : http://erj.ersjournals.com/content/erj/41/3/621.full.pdf
Hidden Killers: Human Fungal Infections, Science Translational Medicine, vol.14, issue.2, pp.165-113, 2012. ,
DOI : 10.1258/0956462981922728
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.21, issue.3, pp.327-360, 2008. ,
DOI : 10.1086/313938
Hepatotoxicity of oral and intravenous voriconazole in relation to cytochrome P450 polymorphisms, Journal of Antimicrobial Chemotherapy, vol.60, issue.5, pp.1104-1107, 2007. ,
DOI : 10.1093/jac/dkm330
URL : https://academic.oup.com/jac/article-pdf/60/5/1104/6959211/dkm330.pdf
Update on the optimal use of voriconazole for invasive fungal infections, Infect Drug Resist, vol.4, pp.43-53, 2011. ,
Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study, European Journal of Pharmaceutical Sciences, vol.21, issue.5, pp.645-653, 2004. ,
DOI : 10.1016/j.ejps.2004.01.005
Comprehensive In Vitro Analysis of Voriconazole Inhibition of Eight Cytochrome P450 (CYP) Enzymes: Major Effect on CYPs 2B6, 2C9, 2C19, and 3A, Antimicrobial Agents and Chemotherapy, vol.53, issue.2, pp.541-551, 2009. ,
DOI : 10.1128/AAC.01123-08
Antimycotic compound, 2016. ,
Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists, Methods Biochem Anal, vol.46, pp.1-265, 2005. ,
DOI : 10.1002/9781118540398
URL : http://doi.org/10.1002/9781118540398
Itraconazole resistance in Aspergillus fumigatus, Antimicrob Agents Chemother, vol.41, pp.1364-1368, 1997. ,
posting date Aspergillus fumigatus isolate AF293 (NCPF 7367), 2014. ,
Antifungal agent breakpoint tables for interpretation of MICs, 2015. ,
A Point Mutation in the 14??-Sterol Demethylase Gene cyp51A Contributes to Itraconazole Resistance in Aspergillus fumigatus, Antimicrobial Agents and Chemotherapy, vol.47, issue.3, pp.1120-1124, 2003. ,
DOI : 10.1128/AAC.47.3.1120-1124.2003
Azole-Resistant Aspergillus fumigatus Isolate with the TR34/L98H Mutation in Both a Fungicide-Sprayed Field and the Lung of a Hematopoietic Stem Cell Transplant Recipient with Invasive Aspergillosis, Journal of Clinical Microbiology, vol.52, issue.5, pp.1724-172603182, 2014. ,
DOI : 10.1128/JCM.03182-13
URL : https://hal.archives-ouvertes.fr/hal-01063888
Oral infection of mice with Salmonella enterica serovar Typhimurium causes meningitis and infection of the brain, BMC Infect Dis, vol.7, pp.651471-2334, 2007. ,
Triazole-resistant Aspergillus fumigatus harbouring G54 mutation: Is it de novo or environmentally acquired?, Journal of Global Antimicrobial Resistance, vol.3, issue.2, pp.69-74, 2015. ,
DOI : 10.1016/j.jgar.2015.01.005
Associated with Treatment Failure1, Emerging Infectious Diseases, vol.15, issue.7, pp.1068-1076, 2009. ,
DOI : 10.3201/eid1507.090043
Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009, Journal of Antimicrobial Chemotherapy, vol.51, issue.6, pp.2116-2118, 2010. ,
DOI : 10.1128/AAC.01092-06
In Vitro and In Vivo Activity of a Novel Antifungal Small Molecule against Candida Infections, PLoS ONE, vol.19, issue.1, 2014. ,
DOI : 10.1371/journal.pone.0085836.s001
Serum Stimulates Growth of and Proteinase Secretion by Aspergillus fumigatus, Infection and Immunity, vol.70, issue.1, pp.19-26, 2002. ,
DOI : 10.1128/IAI.70.1.19-26.2002
, Medical Mycology, vol.39, issue.16, pp.711-717, 2005.
DOI : 10.1128/JCM.39.2.478-484.2001
Antibiotic resistance threats in the United States, 2013: fluconazole-resistant Candida, CDC, 2013. ,
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS, AIDS, vol.23, issue.4, pp.525-530, 2009. ,
DOI : 10.1097/QAD.0b013e328322ffac
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases, Clinical Infectious Diseases, vol.46, issue.2, pp.634-653, 2005. ,
DOI : 10.2214/ajr.144.6.1195
Ligand interactions with cytochrome P-450. I. Binding of primary amines, Biochemistry, vol.8, issue.8, pp.3455-3463, 1969. ,
DOI : 10.1021/bi00836a049
[27] Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical-difference spectroscopy, Methods Enzymol, vol.52, issue.78, pp.258-27910, 1978. ,
DOI : 10.1016/S0076-6879(78)52029-6
Mode of Action and Resistance to Azole Antifungals Associated with the Formation of 14??-Methylergosta-8,24(28)-dien-3??,6??-diol, Biochemical and Biophysical Research Communications, vol.207, issue.3, pp.910-915, 1995. ,
DOI : 10.1006/bbrc.1995.1272
In Vivo Efficacy of Aerosolized Nanostructured Itraconazole Formulations for Prevention of Invasive Pulmonary Aspergillosis, Antimicrobial Agents and Chemotherapy, vol.50, issue.4, pp.1552-1554, 2006. ,
DOI : 10.1128/AAC.50.4.1552-1554.2006
Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis: Figure 1???, European Respiratory Journal, vol.40, issue.1, pp.271-273, 2012. ,
DOI : 10.1183/09031936.00163511
Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients, Transplantation, vol.77, issue.2, pp.232-237, 2004. ,
DOI : 10.1097/01.TP.0000101516.08327.A9
Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance., Antimicrobial Agents and Chemotherapy, vol.31, issue.7, pp.1054-1060, 1987. ,
DOI : 10.1128/AAC.31.7.1054
Antimicrobial pharmacodynamics: critical interactions of 'bug and drug', Nature Reviews Microbiology, vol.19, issue.Suppl., pp.289-300, 2004. ,
DOI : 10.1016/S0924-8579(02)00031-6
Expression, Purification, and Characterization of Aspergillus fumigatus Sterol 14-?? Demethylase (CYP51) Isoenzymes A and B, Antimicrobial Agents and Chemotherapy, vol.54, issue.10, pp.4225-4234, 2010. ,
DOI : 10.1128/AAC.00316-10
Expression and functional characterization of cytochrome P450 26A1, a retinoic acid hydroxylase, Biochemical Pharmacology, vol.77, issue.2, pp.258-268, 2009. ,
DOI : 10.1016/j.bcp.2008.10.012
ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.59, issue.12, pp.7771-7778, 2015. ,
DOI : 10.1128/AAC.01806-15
ABSTRACT, Applied and Environmental Microbiology, vol.79, issue.5, pp.1639-164503246, 2013. ,
DOI : 10.1128/AEM.03246-12
EUCAST definitive document EDef 9.3. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds, 2015. ,
EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*, Clinical Microbiology and Infection, vol.18, issue.7, pp.246-247, 2012. ,
DOI : 10.1111/j.1469-0691.2012.03880.x
EUCAST definitive document EDef 9.2. Method for the determination of broth microdilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds, 2014. ,
, Document M38-A. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard, 2008.
, Antifungal Activity of Novel Azole PC945 Antimicrobial Agents and Chemotherapy Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard
Plasminogen Alleles Influence Susceptibility to Invasive Aspergillosis, PLoS Genetics, vol.11, issue.6, 2008. ,
DOI : 10.1371/journal.pgen.1000101.s004
A new and clinically relevant murine model of solid-organ transplant aspergillosis, Disease Models & Mechanisms, vol.6, issue.3, pp.643-651, 2013. ,
DOI : 10.1242/dmm.010330
Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia, American Journal of Physiology-Lung Cellular and Molecular Physiology, vol.90, issue.4, pp.833-839, 2001. ,
DOI : 10.1164/ajrccm.155.2.9032210
, Antimicrobial Agents and Chemotherapy